Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proviva Pharma is a Canada-based microbiome and probiotic health company focused on developing, manufacturing, and marketing probiotic products and related health solutions. The company positions itself around microbiome innovation for human, animal, dairy, and industrial applications, with stated interests spanning gastrointestinal health, metabolic disease, cardiovascular health, bone health, obesity, and longevity. In addition to commercial probiotic supplements, Proviva Pharma states that it is developing novel medical diagnostic kits tied to its microbiome-focused strategy. Its technology stack includes a large probiotic strain bank, active strain production, and certified GMP manufacturing capabilities. Overall, the company appears to operate as a health and wellness-focused microbiome products company rather than a traditional clinical-stage drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proviva Pharma.